Methanol → 2-methyl-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile
Reaction equation
[CH3:1][C:2]1[N:3]([CH:17]([CH3:21])[CH2:18]SC)[C:4]2[C:9]([CH:10]=1)=[C:8]([C:11]([F:14])([F:13])[F:12])[C:7]([C:15]#[N:16])=[CH:6][CH:5]=2.O[O:23][S:24]([O-:26])=O.[K+].[CH3:28]O>O>[CH3:1][C:2]1[N:3]([CH:17]([CH3:21])[CH2:18][S:24]([CH3:28])(=[O:26])=[O:23])[C:4]2[C:9]([CH:10]=1)=[C:8]([C:11]([F:13])([F:12])[F:14])[C:7]([C:15]#[N:16])=[CH:6][CH:5]=2Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To an ice-cold solution of 2-methyl-1-(1-(methylthio)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile (Example 8) (0.045 g, 0.144 mmol) in MeOH (4 mL) was added a solution of Oxone (0.133 g, 0.216 mmol) in water (2 mL). After 1 h, additional Oxone (0.100 g, 0.163 mmol) was added, and the mixture was stirred at rt. After 30 min, the reaction mixture was diluted with water (10 mL) and extracted with EtOAc (20 mL). The organic phase was washed with brine, dried over Na2SO4, filtered and concentrated. The residue was purified by preparative HPLC (Phenomenex Luna column; gradient: 10-100% MeCN-water with 0.1% TFA). The fractions with product were basified with aq. saturated K2CO3 solution, and then concentrated down to the aqueous phase, which was extracted with EtOAc. The organic phase was washed with brine, dried over Na2SO4, filtered and concentrated to give 2-methyl-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile: MS (ESI): m/z 345 (MH+).
Workup
- waitAfter 30 min
- extractionextracted with EtOAc (20 mL)
- washThe organic phase was washed with brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customThe residue was purified by preparative HPLC (Phenomenex Luna column; gradient: 10-100% MeCN-water with 0.1% TFA)
- concentrationconcentrated down to the aqueous phase, which
- extractionwas extracted with EtOAc
- washThe organic phase was washed with brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-7e427cf4950c4a539effe113aef0107c
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08957104B2
Reaction notes
Loading…